Chris Widenhouse, Ph.D., was a graduate student and postdoctoral fellow in the Department of Materials Science & Engineering from 1990 through 2001.
Dr. Widenhouse graduated from the University of Florida with an M.S. and Ph.D. in Materials Science & Engineering in 1996. He also holds a B.S. in MSE from North Carolina State University and an MBA from Pennsylvania State University.

Dr. Widenhouse is currently Senior Director of R&D at AtriCure, Inc., where he has been since 2017. Prior to AtriCure, Chris worked within Johnson & Johnson for multiple operating companies (Cordis Endovascular, Cordis, Ethicon Endo-Surgery, and Ethicon) over a 16-year period. During that time, he contributed to developments in the areas of cardiovascular combination products, peripheral vascular devices, laparoscopic and thoracic surgical devices for surgical access, surgical stapling and general surgery. In his roles at AtriCure, he has had end-to-end product lifecycle responsibilities for Left Atrial Appendage Management, RF Surgical Ablation, CryoAblation, and CyroNerveBlock product, procedure and technology families, and is currently leading Early Stage Advanced R&D Programs.

In his free time, Dr. Widenhouse is a husband, a father of four, a youth soccer coach and a part-time sheep farmer.